DrugsControl Media Services
DrugsControl.org

News Detail

EMA Suspends Hydroxyprogesterone Caproate in Europe (21-05-2024)

Amsterdam, 21 May 2024: European Medicines Agency (EMA) announced on May 17, 2024 that its Pharmacovigilance Risk Assessment Committee (PRA......
View Details

Source : Pharmatech
European Medicines Agency (EMA) EMA Pharmacovigilance Risk Assessment Committee (PRAC) PRAC 17-hydroxyprogesterone caproate (17-OHPC)

Related News